Mitsubishi Gas Chemical Company, Inc. TSE:4182
Mitsubishi Gas Chemical : Second Quarter Results Presentation Fiscal Year 2025(April 1, 2025-September 30, 2025)
Source: MarketScreener
FY2025 1H
Consolidated Financial ResultsNovember 10, 2025
TSE 4182
+ Increase in sales volume of BT materials
Net Sales
-
Deterioration in polycarbonate (PC) and methanol market prices
Withdrawal from the ortho-xylene (OX) chain business
Operating
profit
Increase in fixed costs due to capacity
expansion for inorganic chemicals
Deterioration in profitability of meta-xylenediamine (MXDA) products
For the Netherlands MXDA plant where temporary suspension of construction was announced, an impairment loss on non-current assets (50.2 billion yen) was recorded as an extraordinary loss in the second quarter.
(Note) Recorded at our consolidated subsidiary MGC Specialty Chemicals Netherlands B.V. (MSCN)
1. FY2025 1H Results | ||
[JPY in billions] | YoY | |
Net Sales | 361.6 | -26.4 |
Operating profit | 25.1 | -8.6 |
Profit attributable to owners of parent | (27.9) | -52.6 |
*No change from previous forecast for either
50 yen*(forecast)
the year-end dividend
Dividend
Policy
in methanol market prices
Interim dividend 50 yen*(confirmed)
Increase in sales volume of BT materials
Deterioration in profitability of MXDA products
Decline in profitability due to deterioration
-
Operating
profit
Increase in sales volume of BT materials
⚫ Deterioration in PC market prices
Decrease in sales volume of inorganic
chemicals
+
Net Sales
+
2. FY2025 Full-Year Forecast | ||
[JPY in billions] | vs. Previous Forecast | |
Net Sales | 730.0 | -20.0 |
Operating profit | 44.0 | -2.0 |
Profit attributable to owners of parent | (17.0) | -53.0 |
(Note) Figures shown on this and the following pages are rounded down to the closest 0.1 billion. Percentage figures, per-share indicators, and performance assumptions are rounded off to the closest whole number.
INDEX1
FY2025 1H Results
2
FY2025 Forecast
3
Results and Forecast by Segment
1
FY2025 1H Results
2
FY2025 Forecast
3
Results and Forecast by Segment
FY2025 1H ResultsNet sales: Despite robust sales of electronics materials, the Group's net sales decreased, mainly due to the impact of the appreciation of the yen, lower market prices for engineering plastics and methanol, and withdrawal from the ortho-xylene chain business.
Operating profit: Declined due primarily to lower market prices for the above offerings and growth in fixed costs associated with the expansion of production capacities of inorganic chemicals. Other factors leading to this decline included sluggish demand for meta-xylenediamine and its derivatives as well as intensifying competition in the market for these products, in addition to the appreciation of the yen.
Ordinary profit: Decreased, due mainly to a decline in equity in earnings of affiliates related to the methanol business on the back of foreign exchange fluctuations and other factors.
Interim loss attributable to owners of parent: Posted due to lower ordinary profit and the impairment of noncurrent assets at a subsidiary engaged in meta-xylenediamine manufacturing in the Netherlands.
Changes | FY2025 1H | ||||||||||
Previous | |||||||||||
[JPY in billions] | FY2024 1H | FY2025 1H | Amount | % | Forecast* | ||||||
Net Sales | 388.1 | 361.6 | -26.4 | -6.8 | 360.0 | ||||||
Operating profit | 33.7 | 25.1 | -8.6 | -25.5 | 24.0 | ||||||
Equity in earnings of affiliates | 5.9 | 2.9 | -2.9 | -50.3 | 3.3 | ||||||
Ordinary profit | 37.4 | 31.4 | -5.9 | -15.9 | 27.0 | ||||||
Profit attributable to owners of parent | 24.7 | (27.9) -52.6 - | 20.0 | ||||||||
*Announced on Aug. 7, 2025 | |||||||||||
E P S (JPY) | 123.47 | (143.48) | 102.71 | ||||||||
FX (JPY/USD) | 153 | 146 | |||||||||
[JPY in billions] | FY2024 1H | FY2025 1H | Changes |
Non-operating items | 3.6 | 6.3 | +2.6 |
Equity in earnings of affiliates | 5.9 | 2.9 | -2.9 |
Financial income or losses | 1.0 | 2.5 | +1.5 |
Foreign exchange gains or losses | (1.9) | 1.5 | +3.5 |
Others | (1.3) | (0.7) | +0.5 |
Extraordinary income | 1.1 | 5.4 | +4.3 |
Gains on sales of noncurrent assets | - | 3.5 | +3.5 |
Gains on sales of investment securities | 0.1 | 1.0 | +0.9 |
Subsidy income | 0.9 | 0.1 | -0.7 |
Others | - | 0.6 | +0.6 |
Extraordinary losses | (1.6) | (51.0) | -49.3 |
Impairment losses | (0.1) | (50.2) | -50.0 |
Provision allowance for doubtful accounts | (0.1) | (0.3) | -0.2 |
Loss on tax purpose reduction entry of noncurrent assets | (0.6) | - | +0.6 |
Others | (0.7) | (0.4) | +0.2 |
Total extraordinary income and losses | (0.5) | (45.6) | -45.0 |
Content of the Difference
Equity in earnings of affiliates
GEC -2.2
Specialty Chemicals -0.7
Content of the Difference
Impairment losses -50.0
・Impairment of MXDA Plant at MSCN, etc.
About the MXDA Europe PlantAims of the project:
Securing a production base in Europe, MXDA's largest market
ー MXDA is one of the meta-xylene derivatives, and its main applications include epoxy resin curing agents, polyamides, and isocyanates.
ー Low-environmental-impact repair materials for wind power generation blades are also being increasingly recognized as a new application, and stable market growth is expected in the future. Currently, our company produces MXDA at two production bases in Japan.
ー In September 2021, we announced plans to construct an MXDA production facility with an annual capacity of 20,000 MT in Europe (Rotterdam industrial zone, Netherlands), the largest market for MXDA.
ー We proceeded with construction, initially aiming to start production in July 2024, through our consolidated subsidiary MGC Specialty Chemicals Netherlands B.V. (MSCN).
Temporary suspension of construction work-impairment loss recordedー In addition to delays in the schedule due to factors including the switch of construction contractors last fiscal year, the business environment for the project has rapidly deteriorated due to soaring construction and labor costs stemming from the Russia-Ukraine conflict along with changes in the competitive environment in the MXDA market.
ー In light of this situation, we resolved and announced the temporary suspension of the construction work at the meeting of the Board of Directors held on September 17, 2025.
ー Following the temporary suspension of construction, as a result of a comprehensive evaluation of the project's economic viability and ability to recoup investment,we recognized a 50.2 billion yen
impairment loss on MSCN's non-current assets in the FY2025 second-quarter consolidated results.
(Note) In the non-consolidated results, we recorded 29.9 billion yen in valuation loss on shares of subsidiaries and affiliates and 21.9 billion yen in provision for business losses of subsidiaries and affiliates, but these are eliminated in the consolidated results.
ー Currently, we are considering all options toward improving profitability for the entire MXDA business, including whether to continue the construction.
FY2025 1H Increase and Decrease Factors of Operating Profit (YoY)(-) Methanol, BT materials, MXDA, etc.
(+) BT materials, etc.
(-) PC, etc.
[JPY in billions]
Quantity factors
+0.6
Forex factors
33.7
25.1
-1.6
(Forex rates*) FY2024 1H: ¥153/$ FY2025 1H: ¥146/$
Price factors
-3.4
Others
-4.2
(-) Depreciation costs, MSCN-related, etc.
OP
-8.6
FY2024 1H FY2025 1H
* Exchange Sensitivity
USD, rough estimate : with an appreciation (depreciation) of ¥1 against the USD, annual operating profit falls (increases) by ¥0.5bn, while annual ordinary profit falls (increases) by ¥0.5bn.
EUR, rough estimate : with an appreciation (depreciation) of ¥1 against the EUR, annual operating profit falls (increases) by ¥0.1bn, while
annual ordinary profit falls (increases) by ¥0.1bn.
1
FY2025 1H Results
2
FY2025 Forecast
3
Results and Forecast by Segment
FY2025 Full-Year Forecastー Based on the impairment loss recorded in the second quarter and recent business trends, we have revised downward our full-year
forecast and expect a net loss for the full year.
ー Although we expect an increase in the sales volume of BT materials, operating profit is expected to decrease due to deterioration in profitability for MXDA and its derivatives, and a decrease in sales volume for chemicals for use in semiconductor manufacturing.
[JPY in billions]
FY2025
Previous
Forecast*1
FY2025
Revised
Forecast
Changes
Amount %
FY2024
Net sales
750.0
730.0-20.0
-2.7
773.5
Operating profit
46.0
44.0-2.0
-4.3
50.8
Ordinary profit
50.0
50.0-
-
60.3
Profit attributable to
owners of parent
36.0
(17.0)-53.0
-
45.5
E P S (JPY) 184.87 (87.30) 228.93
R O E (%) 5.4 - 6.9
R O I C*2 (%) 4.2 3.9 6.4
FX (JPY/USD) 145 146 153
*1 Announced on Aug. 7, 2025
*2 ROIC =(Operating profit - Income taxes + Equity in earnings of affiliates) / invested capital